IP Library Granted Patent US 12,144,716
Granted Patent B2
US 12,144,716 · App. 17/358,463 · Granted Nov 19, 2024

Biomedical patches with aligned fibers

Inventors: Matthew R. MacEwan (St. Louis, MO); Jingwei Xie (St. Louis, MO); Zack Ray (St. Louis, MO); Younan Xia (St. Louis, MO)
Assignee: Washington University
A61F2/02A61F2/0063A61F2/105A61L15/22A61L15/42A61L27/14A61L27/50B29C48/05B29C48/142D01D5/0076D01D5/0092D04H1/728D04H3/016D04H3/073C12M25/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,144,716
App. No.
17/358,463
Granted
Nov 19, 2024
Kind
B2
Abstract

A multi-laminar electrospun nanofiber scaffold for use in repairing a defect in a tissue substrate is provided. The scaffold includes a first layer formed by a first plurality of electrospun polymeric fibers, and a second layer formed by a second plurality of electrospun polymeric fibers. The second layer is combined with the first layer. A first portion of the scaffold includes a higher density of fibers than a second portion of the scaffold, and the first portion has a higher tensile strength than the second portion. The scaffold is configured to degrade via hydrolysis after at least one of a predetermined time or an environmental condition. The scaffold is configured to be applied to the tissue substrate containing the defect, and is sufficiently flexible to facilitate application of the scaffold to uneven surfaces of the tissue substrate, and to enable movement of the scaffold by the tissue substrate.

Claims (28)

1. A method of manufacturing an electrospun graft material for facilitating wound healing, the method comprising:

depositing via electrospinning a first polymer composition and a second polymer composition to form a biomedical wound matrix comprising a first polymeric scaffold and a second polymeric scaffold, the first polymer composition being different from the second polymer composition,

the first polymeric scaffold comprising a first structure of fibers having electrospun nanofibers, the first structure of fibers comprising a plurality of randomly oriented fiber sections, the first structure of fibers configured to promote cell growth upon application of the biomedical wound matrix to a tissue,

the second polymeric scaffold comprising a second structure of fibers having electrospun nanofibers, the second structure of fibers comprising a plurality of substantially straight fiber sections and a plurality of randomly oriented fiber sections,

wherein one or more of the plurality of substantially straight fiber sections transition into one or more of the plurality of randomly oriented fiber sections of the second structure of fibers, wherein one or more of the plurality of randomly oriented fiber section is overlaid on one or more of the substantially straight fiber sections,

the second structure of fibers configured to provide structural reinforcement to the first polymeric scaffold,

wherein the biomedical wound matrix is sufficiently flexible to facilitate application of the biomedical wound matrix to uneven surfaces of the tissue, and

wherein the biomedical wound matrix is sufficiently flexible to enable movement of the biomedical wound matrix with the tissue; and

customizing the biomedical wound matrix to a particular size to obtain the electrospun graft material.

2. The method of claim 1 , wherein a first portion of the electrospun graft material of a particular size comprises a higher number of fibers than a second portion of the electrospun graft material of a particular size.

3. The method of claim 1 , further comprising forming a pattern on a surface of the biomedical wound matrix.

4. The method of claim 3 , wherein the pattern on the surface of the biomedical wound matrix is formed by positioning a mask between a collector and a spinneret, wherein the mask is configured to prevent depositing at least some of the first structure of fibers or the second structure of fibers on the collector.

5. The method of claim 3 , wherein the pattern on the surface of the biomedical wound matrix is formed by depositing the first structure of fibers and the second structure of fibers directly on a collector without a mask.

6. The method of claim 5 , wherein the pattern comprises a plurality of organized features.

7. The method of claim 1 , wherein at least a portion of the first structure of fibers and at least a portion of the second structure of fibers are deposited simultaneously.

8. The method of claim 1 , wherein the biomedical wound matrix further comprises a surface pattern, the surface pattern comprising a plurality of structural features configured to align cells.

9. The method of claim 1 , wherein the biomedical wound matrix comprises one or more uniaxially aligned fiber sections.

10. The method of claim 1 , wherein the biomedical wound matrix comprises one or more radially aligned fiber sections.

11. The method of claim 1 , wherein the electrospun graft material comprises one or more surfaces configured to contact tissue upon application of the electrospun graft material.

12. The method of claim 11 , wherein the one or more surfaces comprise a plurality of structural features configured to facilitate cell growth.

13. The method of claim 11 , wherein the one or more surfaces comprise a plurality of structural features configured to aligned cells.

14. The method of claim 1 , wherein the electrospun graft material comprises a plurality of directional cues configured to promote growth of tissue in one or more directions.

15. The method of claim 1 , further comprising sterilizing the electrospun graft material.

16. The method of claim 1 , further comprising sterilizing the biomedical wound matrix.

17. The method of claim 1 , wherein the tissue comprises one or more of skin, dura mater, heart valve leaflets, cardiac tissue, trachea, gastrointestinal tract, or pericardium.

18. The method of claim 1 , wherein the first polymer composition comprises glycolic acid, and wherein the second polymer composition comprises caprolactone.

19. The method of claim 1 , wherein the biomedical wound matrix comprises one or more anisotropic properties.

20. The method of claim 1 , wherein the biomedical wound matrix comprises one or more anisotropic properties.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 6, 2023
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065788/0877 →
CORRECTIVE ASSIGNMENT TO CORRECT THE 4TH INVENTOR'S NAME PREVIOUSLY RECORDED AT REEL: 056669 FRAME: 0386. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jul 6, 2021
From: MACEWAN, MATTHEW R.; XIA, YOUNAN; XIE, JINGWEI; RAY, ZACK
To: WASHINGTON UNIVERSITY
Reel/Frame 056769/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2021
From: MACEWAN, MATTHEW R.; XIA, YOUNAN; XIE, JINGWEI; RAY, ZACH
To: WASHINGTON UNIVERSITY
Reel/Frame 056669/0386 →
Continuity (7)
Continuation 17063924 · Oct 6, 2020
Continuation 16795057 · Feb 19, 2020
Continuation 16540548 · Aug 14, 2019
Continuation 15497691 · Apr 26, 2017
Continuation 13703210
Related Publication 20210338408A1 · Nov 4, 2021
Related Publication 20230053327A9 · Feb 16, 2023
Cited By (1)
US 12,564,658